A caution-in-use communication has been issued for:
Download the reminder caution-in-use communication dated 14 December 2020.
Sinemet® Plus (carbidopa/levodopa) 25mg/100mg Tablets- PA1286/9/4
Sinemet® (carbidopa/levodopa) 12.5mg/50mg Tablets - PA1286/9/2
The communication contains important reminder information for healthcare professionals. It is a reminder letter of information conveyed on 2 June 2020 regarding changes to guidance on Sinemet tablet subdivision and tablet removal from the blister packaging.
Download the caution-in-use letter issued on 2 June 2020.